Role of clinical evaluation in the identification of coronary obstructive disorders in patients with stable coronary artery disease. Part I
https://doi.org/10.15829/1560-4071-2019-5-95-100
Abstract
To make a decision on choice the type of myocardial revascularization in patients with coronary artery disease (CAD), an invasive coronary angiography (CAG) is necessary. However, in clinical practice, a significant number of patients during CAG fails to detect coronary obstructive disorders, there is the so-called problem of “clean” coronary arteries. Indeed, in the Russian Federation in approximately 50% of cases, CAG does not end with myocardial revascularization, and in patients with suspected CAD, non-obstructive coronary artery lesions are detected in 67% of cases. In the first part of the review, a critical analysis of the clinical evaluation of patients in the selection of patients for CAG was conducted. First stages of the diagnostic process based on clinical evaluation are considered. The review discusses the use for diagnostic purposes more complete set of routine assessment methods and the expanded use of laboratory tests using memetic algorithms.
About the Author
A. N. Sumin
Research Institute for Complex Problems of Cardiovascular Diseases
Russian Federation
Competing Interests:
Russian Federation
Kemerovo
Competing Interests:
nothing to declare
References
1. Neumann FJ, Sousa-Uva M, Ahlsson A, et al. ESC Scientific Document Group.2018 ESC/ EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40 (2):87—165. doi:10.1093/eurheartj/ehy394.
2. Patel MR, Peterson ED, Dai D, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010;362 (10):886-95. doi:10.1056/NEJMoa0907272.
3. Patel MR, Dai D, Hernandez AF, et al. Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice. Am Heart J. 2014;167:846-52. doi:10.1016/j.ahj.2014.03.001.
4. Gaisenok OV, Martsevich SYu. Determination of Indications for Coronary Angiography in Asymptomatic Patients and Patients With Stable Angina. Kardiologiya. 2014;10:57-62. (In Russ.)
5. Sumin AN, Korok EV, Sinkov MA, et al. The Problem of Minimally Changed Coronary Arteries at Elective Coronary Angiography. Kardiologiya. 2017;4:10-8. (In Russ.) doi:10.18565/cardio.2017.4.10-18.
6. Korok EV, Sumin AN. Current issues of CHD diagnosis in materials of the Russian cardiology congress (Ekaterinburg, 20-23 September 2016). Complex Issues of Cardiovascular Diseases. 2017; (1):131-40. (In Russ.) doi:10.17802/2306-1278-2017-1-131-140.
7. Rio P, Ramos R, Pereira-da-Silva T, et al. Yield of contemporary clinical strategies to detect patients with obstructive coronary artery disease. Heart Int. 2016;10 (1): e12-9. doi:10.5301/heartint.5000224.
8. Alekyan BG, Grigoryan AM, Staferov AV, Karapetyan NG. Endovascular diagnostics and treatment in the Russian Federation (2017). Endovaskulyarnaya hirurgiya. 2018;2:93-240. (In Russ.) doi:10.24183/2409-4080-2018-5-2-93-240.
9. Korok EV, Sumin AN, Sinkov MA, et al. The prevalence of intact coronary arteries in relation with indications for scheduled coronary arteriography. Russ J Cardiol. 2016;2:52-9. (In Russ doi: 10.15829/1560-4071-2016-2-52-59.
10. Wang ZJ, Zhang LL, Elmariah S, et al. Prevalence and Prognosis of Nonobstructive Coronary Artery Disease in Patients Undergoing Coronary Angiography or Coronary Computed Tomography Angiography: A Meta-Analysis. Mayo Clin Proc. 2017;92 (3):329-46. doi:10.1016/j.mayocp.2016.11.016.
11. Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60: e44-e164, doi:10.1016/j.jacc.2012.07.013.
12. Montalescot G, Sechtem U, Achenbach S, et al. Task Force Members; 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949-3003. doi:10.1093/eurheartj/eht296.
13. Smeeth L, Skinner JS, Ashcroft J, et al. Chest Pain Guideline Development Group. NICE clinical guideline: chest pain of recent onset. Br J Gen Pract. 2010;60 (577):607-10. doi:10.3399/bjgp10X515124.
14. Han PP, Tian YQ, Fang W, et al. Impact of myocardial perfusion imaging on in-hospital coronary angiography and revascularization of patients with suspected coronary artery disease. Chin Med J (Engl). 2011;124:1603-9.
15. Genders TS, Steyerberg EW, Alkadhi H, et al. A clinical prediction rule for the diagnosis of coronary artery disease: Validation, updating, and extension. Eur Heart J. 2011;32:1316-30. doi:10.1093/eurheartj/ehr014.
16. Nakas G, Bechlioulis A, Marini A, et al. The importance of characteristics of angina symptoms for the prediction of coronary artery disease in a cohort of stable patients in the modern era. Hellenic J Cardiol. 2018 Jun 8. pii: S1109-9666 (18) 30027-7. doi:10.1016/j.hjc.2018.06.003. [Epub ahead of print]
17. Tashakkor AY, Stone J, Mancini GB. Is it time to update how suspected angina is evaluated prior to the use of specialized tests implications based on a systematic review. Cardiology. 2016;133 (3):181-90. doi:10.1159/000441562.
18. Hendel RC. Utilization management of cardiovascular imaging pre-certification and appropriateness. JACC Cardiovasc Imaging. 2008;1 (2):241-8. doi:10.1016/j.jcmg.2008.01.008.
19. Mohareb MM, Qiu F, Cantor WJ, et al. Validation of the appropriate use criteria for coronary angiography: a cohort study. Ann Intern Med. 2015;162:549-56. doi:10.7326/M14-1889.
20. Douglas PS, Hoffmann U, Patel MR, et al. PROMISE Investigators: Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med. 2015;372:1291-1300. doi:10.1056/NEJMoa1415516.
21. SCOT-HEART Investigators: CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOTHEART): an open-label, parallel-group, multicentre trial. Lancet. 2015;385:2383-91. doi:10.1016/S0140-6736(15)60291-4.
22. Lansky A, Elashoff MR, Ng V, et al. A gender-specific blood-based gene expression score for assessing obstructive coronary artery disease in nondiabetic patients: results of the Personalized Risk Evaluation and Diagnosis in the Coronary Tree (PREDICT) trial. Am Heart J. 2012;164:320-6. doi:10.1016/j.ahj.2012.05.012.
23. Zellweger MJ, Tsirkin A, Vasilchenko V, et al. A new non-invasive diagnostic tool in coronary artery disease: artificial intelligence as an essential element of predictive, preventive, and personalized medicine. EPMA J. 2018;9 (3):235-47. doi:10.1007/s13167-018-0142-x.
Review
For citations:
Sumin A.N. Role of clinical evaluation in the identification of coronary obstructive disorders in patients with stable coronary artery disease. Part I. Russian Journal of Cardiology. 2019;(5):95-100. (In Russ.) https://doi.org/10.15829/1560-4071-2019-5-95-100
Views:
730
Email this article 